InVivo Therapeutics Holdings Corp (NVIVQ)

[BesaoT35]

There are since last reported 4 more patients until enrollment in Inspire 2 is complete. They will not report each individual new enrollment it seems. They will report when enrollment is complete however I think.

I remember a long time ago when Inspire 1 was going there was an excitement and a dramatic run up in price per share. We had a few deaths that were unrelated but the stock did tank. The FDA made the testing more arduous at that time also.

Now it seems that if results are good that we are farther down the road than we were then when investors were so optimistic.